Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 30+ AI models, with 0% extra fees
Just caught this from a while back - HeartBeam made some leadership moves back in late 2024. Robert Eno stepped up as CEO while Branislav Vajdic, who founded the company, shifted over to President. Kind of interesting how they structured this transition, honestly.
Eno came in as President a couple years prior and had solid MedTech background - spent time at Preview Medical as CEO before that, plus roles at HeartFlow and some other medical device companies. Seems like they brought him in specifically to handle the business side while Branislav Vajdic could focus more on the tech innovation piece.
From what I understand, Branislav Vajdic is still pretty hands-on with their vector-based technology and AI applications development. The company's still working on FDA clearance for their core tech, so having someone like Vajdic focused on R&D while Eno manages the CEO operational side makes sense for a company at that stage. Pretty typical MedTech play when you need both innovation and business execution running in parallel.